2-[2-(4-bromophenoxy)ethyl]-5-ethylpyridine

• ChemBase编号: 163003
• 分子式: C15H16BrNO
• 平均质量: 306.19764
• 单一同位素质量: 305.04152614
• SMILES: c1(cnc(cc1)CCOc1ccc(cc1)Br)CC
• Canonical SMILES: CCc1ccc(nc1)CCOc1ccc(cc1)Br
• InChI: InChI=1S/C15H16BrNO/c1-2-12-3-6-14(17-11-12)9-10-18-15-7-4-13(16)5-8-15/h3-8,11H,2,9-10H2,1H3
• InChIKey: DOZJKXJBAFQCPO-UHFFFAOYSA-N

名称和登记号

名称

• IUPAC标准名: 2-[2-(4-bromophenoxy)ethyl]-5-ethylpyridine
• IUPAC传统名: 2-[2-(4-bromophenoxy)ethyl]-5-ethylpyridine
• 别名: 4-[2-(5-Ethyl-2-pyridyl)ethoxy]-1-bromobenzene; 2-[2-(4-Bromophenoxy)ethyl]-5-ethylpyridine

登记号

• CAS号: 669716-58-9
• PubChem SID: 162257138
• PubChem CID: 71314268

理论计算性质

• 质子受体: 2
• 质子供体: 0
• LogD (pH = 5.5): 4.0105534
• LogD (pH = 7.4): 4.3603525
• Log P: 4.3676023
• 摩尔折射率: 76.4191 cm^3
• 极化性: 29.610353 Å^3
• 极化表面积: 22.12 Å^2
• 可自由旋转的化学键: 5
• 里宾斯基五规则: true

详细说明

Toronto Research Chemicals - B686390

An impurity of Pioglitazone (P471000), which is a prescription drug of the class thiazolidinedione (TZD) with hypoglycemic (antihyperglycemic, antidiabetic) action.

参考文献

• Kumar, Y., et al.: Pharmazie, 59, 836 (2004)